This inventor holds 3 USPTO granted patents. Top assignees: Applied Research Systems Ars Holding N.v., Laboratories Serono Sa, Merck Serono S. a.. Active years: 2006-2010.
Company Filing History:

Years Active: 2006-2010
Title: The Innovations of Stephen Hillier
Introduction
Stephen Hillier is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of reproductive medicine, particularly through his innovative patents. With a total of 3 patents, Hillier's work focuses on the use of gonadotrophins in treating anovulatory women.
Latest Patents
Hillier's latest patents include groundbreaking inventions aimed at improving fertility treatments. One of his notable patents is titled "Gonadotrophins in the treatment of anovulatory women." This invention relates to the use of gonadotrophins for inducing folliculogenesis in women who do not ovulate. Specifically, it discusses the administration of LH (or an equivalent dosage of hCG) to produce a medicament that induces folliculogenesis at specified daily doses. In certain embodiments, LH may be used in conjunction with FSH. Another significant patent is "Use of LH in controlled ovarian hyperstimulation." This invention provides a new application for LH and its analogues to aid folliculogenesis during controlled ovarian hyperstimulation (COH). The LH or an analogue is administered during a priming period from day 1 to about day 4 of the stimulatory phase in COH.
Career Highlights
Throughout his career, Stephen Hillier has worked with prominent companies in the pharmaceutical industry. Notable among these are Merck Serono S.A. and Applied Research Systems Ars Holding N.V. His work in these organizations has contributed to advancements in reproductive health and fertility treatments.
Collaborations
Hillier has collaborated with esteemed colleagues in his field, including Stephen Franks and Colin Michael Howles. These partnerships have fostered innovation and development in reproductive medicine.
Conclusion
Stephen Hillier's contributions to the field of reproductive medicine through his patents and collaborations highlight his commitment to improving fertility treatments. His innovative approaches continue to influence the industry and provide hope for many women facing challenges with ovulation.